Neoplasm Recurrence, LocalDisease-Free SurvivalPrognosisNeoplasm StagingRecurrenceTreatment OutcomeSurvival AnalysisSurvival RateRetrospective StudiesFollow-Up StudiesBreast NeoplasmsCell SurvivalKaplan-Meier EstimateCombined Modality TherapyAntineoplastic Combined Chemotherapy ProtocolsTime FactorsSurvivalTumor Markers, BiologicalProportional Hazards ModelsGraft SurvivalChemotherapy, AdjuvantLymphatic MetastasisRadiotherapy, AdjuvantNeoplasm MetastasisLiver NeoplasmsProspective StudiesMultivariate AnalysisLung NeoplasmsImmunohistochemistryAntineoplastic AgentsRisk FactorsNeoplasm GradingAdenocarcinomaDisease ProgressionPredictive Value of TestsNeoplasm InvasivenessFluorouracilCarcinoma, HepatocellularCohort StudiesColorectal NeoplasmsCisplatinCarcinoma, Squamous CellNeoadjuvant TherapyBrain NeoplasmsCyclophosphamideRadiotherapy DosageCarcinoma, Non-Small-Cell LungFree RadicalsVincristineBone NeoplasmsCarcinomaDoxorubicinSarcomaDrug Administration ScheduleReceptors, EstrogenUrinary Bladder NeoplasmsRisk AssessmentReceptor, erbB-2ChemoradiotherapyOvarian NeoplasmsProstatic NeoplasmsGene Expression Regulation, NeoplasticRadiotherapyLymph Node ExcisionRemission InductionPostoperative ComplicationsSalvage TherapyAge FactorsReceptors, ProgesteroneCell Line, TumorKi-67 AntigenProstatectomyMethotrexateDose FractionationEtoposideCarcinoma, Ductal, BreastPrednisoneBrachytherapyLiver TransplantationDeoxycytidineCarboplatinApoptosisHead and Neck NeoplasmsTumor BurdenOrganoplatinum CompoundsImmunoenzyme TechniquesNeoplasm, ResidualStomach NeoplasmsLymph NodesCell ProliferationAntineoplastic Agents, AlkylatingNasopharyngeal NeoplasmsAntibodies, Monoclonal, HumanizedAntimetabolites, AntineoplasticLeucovorinTissue Array AnalysisRadiotherapy, Intensity-ModulatedHodgkin DiseaseRandomized Controlled Trials as TopicGlioblastoma